Carlos R. Bachier, MD, discusses the investigational CAR T-cell therapy lisocabtagene maraleucel in diffuse large B-cell lymphoma.
Carlos R. Bachier, MD
Advertisement
Articles by Carlos R. Bachier, MD
Carlos R. Bachier, MD, program director of Sarah Cannon Center for Blood Cancer, Sarah Cannon Research Institute, discusses the relationship between chimeric antigen receptor (CAR) T-cell therapy and stem cell transplant.
Advertisement
Latest Updated Articles
Dr. Bachier Discusses CAR T-Cell Therapy and Stem Cell TransplantPublished: March 13th 2018 | Updated:
Dr. Bachier on the Potential Benefits of Liso-Cel in DLBCLPublished: September 17th 2020 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
M. Peter Marinkovich, MD, on Integrating Gene Therapy into Clinical Practice for Dermatologists
2
Quarter Century Update: The Continued Unknowns of Cell and Gene Therapy
3
Quarter Century Update: How can Partnerships Between Academia, Biotech, and Pharma be Better Structured?
4
